Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

122 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults.
Allen DB, Backeljauw P, Bidlingmaier M, Biller BM, Boguszewski M, Burman P, Butler G, Chihara K, Christiansen J, Cianfarani S, Clayton P, Clemmons D, Cohen P, Darendeliler F, Deal C, Dunger D, Erfurth EM, Fuqua JS, Grimberg A, Haymond M, Higham C, Ho K, Hoffman AR, Hokken-Koelega A, Johannsson G, Juul A, Kopchick J, Lee P, Pollak M, Radovick S, Robison L, Rosenfeld R, Ross RJ, Savendahl L, Saenger P, Sorensen HT, Stochholm K, Strasburger C, Swerdlow A, Thorner M. Allen DB, et al. Among authors: backeljauw p. Eur J Endocrinol. 2016 Feb;174(2):P1-9. doi: 10.1530/EJE-15-0873. Epub 2015 Nov 12. Eur J Endocrinol. 2016. PMID: 26563978 Free PMC article.
Insulin-like growth factor-I in growth and metabolism.
Backeljauw P, Bang P, Dunger DB, Juul A, Le Bouc Y, Rosenfeld R. Backeljauw P, et al. J Pediatr Endocrinol Metab. 2010 Jan-Feb;23(1-2):3-16. doi: 10.1515/jpem.2010.23.1-2.3. J Pediatr Endocrinol Metab. 2010. PMID: 20432800 Review.
Recombinant human growth hormone plus recombinant human insulin-like growth factor-1 coadministration therapy in short children with low insulin-like growth factor-1 and growth hormone sufficiency: results from a randomized, multicenter, open-label, parallel-group, active treatment-controlled trial.
Backeljauw PF, Miller BS, Dutailly P, Houchard A, Lawson E, Hale DE, Reiner B, Sperling MA; MS316 Study Group. Backeljauw PF, et al. Horm Res Paediatr. 2015;83(4):268-79. doi: 10.1159/000371799. Epub 2015 Mar 6. Horm Res Paediatr. 2015. PMID: 25765099 Free article. Clinical Trial.
122 results